Recent advances in the surgical care of breast cancer patients

Alessandra Mascaro, Massimo Farina, Raffaella Gigli, Carlo E Vitelli, Lucio Fortunato, Alessandra Mascaro, Massimo Farina, Raffaella Gigli, Carlo E Vitelli, Lucio Fortunato

Abstract

A tremendous improvement in every aspect of breast cancer management has occurred in the last two decades. Surgeons, once solely interested in the extipartion of the primary tumor, are now faced with the need to incorporate a great deal of information, and to manage increasingly complex tasks. As a comprehensive assessment of all aspects of breast cancer care is beyond the scope of the present paper, the current review will point out some of these innovations, evidence some controversies, and stress the need for the surgeon to specialize in the various aspects of treatment and to be integrated into the multidisciplinary breast unit team.

Figures

Figure 1
Figure 1
A simple and standardized protocol, with slicing at three levels at 100-micron intervals and double staining with both hematoxylin-eosin and immunohistochemistry, that has allowed the pathologists in the authors' group to diagnose additional nodal disease with an increment of nearly two thirds compared with standard, single-section analysis of the lymph nodes stained with hematoxylin-eosin. (Adapted from Fortunato L, Amini M, Costarelli L, et al. A standardized sentinel lymph node enhanced pathology protocol (SEPP) in patients with breast cancer. J Surg Oncol 2007;96[6]:471; with permission.)

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics. CA Cancer J Clin. 2008;58:71–96. doi: 10.3322/CA.2007.0010.
    1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32. doi: 10.1056/NEJMoa020989.
    1. Fisher B, Anderson S, Redmond CK, Woolmer N, Wickersham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456–61. doi: 10.1056/NEJM199511303332203.
    1. Tabard L, Yen MF, Vita B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003;361:1405–10. doi: 10.1016/S0140-6736(03)13143-1.
    1. Menes TS, Tartter PI, Bleiweiss I, Godbold JH, Seabrook A, Smith SR. The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol. 2005;12:881–5. doi: 10.1245/ASO.2005.03.021.
    1. Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol. 2002;9:994–8. doi: 10.1007/BF02574518.
    1. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2006;18:CD001877.
    1. Jortay AM, Daled H, Faverly D. Contribution of hook-guided breast biopsy to the pathological diagnosis of mammographic lesions. Acta Chir Belg. 1999;99:26–9.
    1. Rissanen TJ, Mäkäräinen HP, Mattila SI, Karttunen AI, Kiviniemi HO, Kallioinen MJ, Kaarela OI. Wire localized biopsy of breast lesions: a review of 425 cases found in screening or clinical mammography. Clin Radiol. 1993;47:14–22. doi: 10.1016/S0009-9260(05)81207-3.
    1. Mokbel K, Ahmed M, Nash A, Sacks N. Re-excision operations in nonpalpable breast cancer. J Surg Oncol. 1995;58:225–8. doi: 10.1002/jso.2930580405.
    1. Intra M, de Cicco C, Gentilini O, Luini A, Paganelli G. Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of Oncology. Eur J Nucl Med Mol Imaging. 2007;34:957–8. doi: 10.1007/s00259-007-0397-2.
    1. Ricart Selma V, González Noguera PJ, Camps Herrero J, Martínez Rubio C, Lloret Martí MT, Torregrosa Andrés A. US-guided localization of non-palpable breast cancer and sentinel node using 99 mTechnetium-albumin colloid] Radiologia. 2007;49:329–34. doi: 10.1016/S0033-8338(07)73787-6.
    1. Lavoué V, Nos C, Clough KB, Baghaie F, Zerbib E, Poulet B, Lefrère Belda MA, Ducellier A, Lecuru F. Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma. Ann Surg Oncol. 2008;15:2556–61. doi: 10.1245/s10434-008-9994-y.
    1. Gennari R, Galimberti V, De Cicco C, Zurrida S, Zerwes F, Pigatto F, Luini A, Paganelli G, Veronesi U. Use of technetium-99 m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions. J Am Coll Surg. 2000;190:692–8. doi: 10.1016/S1072-7515(00)00272-6.
    1. Tanis PJ, Deurloo EE, Valdés Olmos RA, Rutgers EJ, Nieweg OE, Besnard AP, Kroon BB. Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol. 2001;8:850–5. doi: 10.1007/s10434-001-0850-6.
    1. Ronka R, Krogerus L, Leppanen E, von Smitten K, Leidenius M. Radio-guided occult lesion localization in patients undergoing breast-conservin surgery and sentinel node biopsy. Am J Surg. 2004;187:491–496. doi: 10.1016/j.amjsurg.2003.12.040.
    1. Thind CR, Desmond S, Harris O, Nadeem R, Chagla LS, Audisio RA. Radio-guided localization of clinically occult breast lesions (ROLL): a DGH experience. Clin Radiol. 2005;60:681–6. doi: 10.1016/j.crad.2004.12.004.
    1. van Rijk MC, Tanis PJ, Nieweg OE, Loo CE, Olmos RA, Oldenburg HS, Rutgers EJ, Hoefnagel CA, Kroon BB. Sentinel node biopsy and concomitant probe-guided tumor excision of nonpalpable breast cancer. Ann Surg Oncol. 2007;14:627–32. doi: 10.1245/s10434-006-9070-4.
    1. Moreno M, Wiltgen JE, Bodanese B, Schmitt RL, Gutfilen B, da Fonseca LM. Radioguided breast surgery for occult lesion localization - correlation between two methods. J Exp Clin Cancer Res. 2008;27:29. doi: 10.1186/1756-9966-27-29.
    1. Medina-Franco H, Abarca-Pérez L, García-Alvarez MN, Ulloa-Gómez JL, Romero-Trejo C, Sepúlveda-Méndez J. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation. J Surg Oncol. 2008;97:108–11. doi: 10.1002/jso.20880.
    1. Lavoué V, Nos C, Clough KB, Baghaie F, Zerbib E, Poulet B, Lefrère Belda MA, Ducellier A, Lecuru F. Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma. Ann Surg Oncol. 2008;15:2556–61. doi: 10.1245/s10434-008-9994-y.
    1. Van Esser S, Hobbelink M, Ploeg IM Van der, Mali WP, Van Diest PJ, Borel Rinkes IH, Van Hillegersberg R. Radio guided occult lesion localization (ROLL) for non-palpable invasive breast cancer. J Surg Oncol. 2008;98:526–9. doi: 10.1002/jso.21143.
    1. Sarlos D, Frey LD, Haueisen H, Landmann G, Kots LA, Schaer G. Radioguided occult lesion localization (ROLL) for treatment and diagnosis of malignant and premalignant breast lesions combined with sentinel node biopsy: a prospective clinical trial with 100 patients. Eur J Surg Oncol. 2009;35:403–8.
    1. Zgajnar J, Hocevar M, Frkovic-Grazio S, Hertl K, Schweiger E, Besic N. Radioguided occult lesion localization (ROLL) of the non palpable breast lesions. Neoplasma. 2004;51:385–9.
    1. Nadeem R, Chagla LS, Harris O, Desmond S, Thind R, Titterrell C, Audisio RA. Occult breast lesions: A comparison between radioguided occult lesion localisation (ROLL) vs. wire-guided lumpectomy (WGL) Breast. 2005;14:283–9. doi: 10.1016/j.breast.2005.04.002.
    1. Rampaul RS, Bagnall M, Burrell H, Pinder SE, Evans AJ, Macmillan RD. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg. 2004;91:1575–7. doi: 10.1002/bjs.4801.
    1. Ploeg IM van der, Hobbelink M, Bosch MA van den, Mali WP, Borel Rinkes IH, van Hillegersberg R. 'Radioguided occult lesion localisation' (ROLL) for non-palpable breast lesions: a review of the relevant literature. Eur J Surg Oncol. 2008;34:1–5.
    1. Harlow SP, Krag DN, Ames SE, Weaver DL. Intraoperative ultrasound localization to guide surgical excision of nonpalpable breast carcinoma. J Am Coll Surg. 1999;189:241–6. doi: 10.1016/S1072-7515(99)00156-8.
    1. Smith LF, Rubio IT, Henry-Tillman R, Korourian S, Klimberg VS. Intraoperative ultrasound-guided breast biopsy. Am J Surg. 2000;180:419–23. doi: 10.1016/S0002-9610(00)00500-6.
    1. Kaufman CS, Jacobson L, Bachman B, Kaufman L. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg. 2003;186:378–82. doi: 10.1016/S0002-9610(03)00278-2.
    1. Bennet IC, Greenslade J, Chiam H. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. World J Surg. 2005;29:369–74. doi: 10.1007/s00268-004-7554-6.
    1. Ngô C, Pollet AG, Laperrelle J, Ackerman G, Gomme S, Thibault F, Fourchotte V, Salmon RJ. Intraoperative ultrasound localization of nonpalpable breast cancers. Ann Surg Oncol. 2007;14:2485–9. doi: 10.1245/s10434-007-9420-x.
    1. Haid A, Knauer M, Dunzinger S, Jasarevic Z, Köberle-Wührer R, Schuster A, Toeppker M, Haid B, Wenzl E, Offner F. Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer. Ann Surg Oncol. 2007;14:3090–101. doi: 10.1245/s10434-007-9490-9.
    1. Fortunato L, Penteriani R, Farina M, Vitelli CE, Piro FR. Intraoperative ultrasound is an effective and preferable technique to localize non-palpable breast tumors. Eur J Surg Oncol. 2008;34:1289–92.
    1. Nagashima T, Hashimoto H, Oshida K, Nakano S, Tanabe N, Nikaido T, Koda K. Miyazaki M.Ultrasound demonstration of mammographic detected microcalcifications in patients with ductal carcinoma in situ of the breast. Breast Cancer. 2005;12:216–20. doi: 10.2325/jbcs.12.216.
    1. Kurtz JM, Almaric R, Brandone H, Ayme Y, Jacquemier J, Pietra JC, Hans D, Pollet JF, Bressac C, Spitalier JM. Local recurrence after breast conserving surgery and radiotherapy. Cancer. 1989;63:1912–17. doi: 10.1002/1097-0142(19890515)63:10<1912::AID-CNCR2820631007>;2-Y.
    1. Huston TL, Simmons RM. Locally recurrent breast cancer after conservation therapy. The American Journal of Surgery. 2005;189:229–235. doi: 10.1016/j.amjsurg.2004.07.039.
    1. Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer. 2006;106:35–41. doi: 10.1002/cncr.21551.
    1. Lim W, Park EH, Choi SL, Seo JY, Kim HJ, Chang MA, Ku BK, Son B, Ahn SH. Breast conserving surgery for multifocal breast cancer. Ann Surg. 2009;249:87–90. doi: 10.1097/SLA.0b013e31818e41c0.
    1. Jobsen JJ, Riemersa S, Palen J van der, Ong F, Jonkman A, Struikmar H. The impact of margin status in breast-conserving therapy for lobular carcinoma is age related. Eur J Surg col. 2009.
    1. Fourquet A, Campana F, Zafrani B, Mosseri V, Vielh P, Durand JC, Vilcoq JR. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys. 1989;17:719–725.
    1. Locker AP, Ellis IO, Morgan DA, Elston CW, Mitchell A, Blamey RW. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg. 1989;76:890–894. doi: 10.1002/bjs.1800760906.
    1. Jobsen JJ, Palen J van der, Meerwaldt JH. The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy. Eur J Cancer. 2001;37:1820–1827. doi: 10.1016/S0959-8049(01)00173-3.
    1. Antonini N, Jones H, Horiot JC, Poortmans P, Struikmans H, Bogaert W Van den, Barillot I, Fourquet A, Jager J, Hoogenraad W, Collette L, Pierart M, Hart G, Bartelink H. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol. 2007;82:265–71. doi: 10.1016/j.radonc.2006.09.014.
    1. Dillon MF, Hill A, Quinn C, McDermott E, O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Annals Surg Oncol. 2006;13:333–339. doi: 10.1245/ASO.2006.03.098.
    1. Jacobs L. Positive Margins: The Challenge Continues for Breast Surgeons. Ann Surg Oncol. 2008;15:1271–1272. doi: 10.1245/s10434-007-9766-0.
    1. Bollet MA, Sigal-Zafrani B, Mazeau V. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. Radiother Oncol. 2007;82:272–80. doi: 10.1016/j.radonc.2007.01.001.
    1. Renton SC, Gazet JC, Ford HT, Corbishley C, Sutcliffe R. The impact of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol. 1996;22:17–22. doi: 10.1016/S0748-7983(96)91253-6.
    1. Mansfield CM, Komarnicky LT, Schwartz GF, Rosenberg AL, Krishnan L, Jewell WR, Rosato FE, Moses ML, Haghbin M, Taylor J. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer. 1995;75:2328–2336. doi: 10.1002/1097-0142(19950501)75:9<2328::AID-CNCR2820750923>;2-L.
    1. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002;184:383–393. doi: 10.1016/S0002-9610(02)01012-7.
    1. Smitt MC, Nowels K, Carlson RW, Stockdale FE, Goffinet DR. Predictor of reexcision findings and recurrence after breast conservation. Int J Radiot Oncol Biol Phys. 2003;57:979–985. doi: 10.1016/S0360-3016(03)00740-5.
    1. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366:2087–106.
    1. Fatouros M, Roukos DH, Arampatzis I, Sotiriadis A, Paraskevaidis E, Kappas AM. Factors increasing local recurrence in breast-conserving surgery. Expert Rev Anticancer Ther. 2005;5:737–45. doi: 10.1586/14737140.5.4.737.
    1. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991;338:327–331. doi: 10.1016/0140-6736(91)90475-5.
    1. Arriagada R, Lê MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996;14:1558–64.
    1. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, Gallus G, Greco M, Luini A, Marubini E, Muscolino G, Rilke F, Salvadori B, Zecchini A, Zucali R. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305:6–11.
    1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41. doi: 10.1056/NEJMoa022152.
    1. Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, Mouridsen HT. Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Bethesda, Md.: National Cancer Institute; 1992. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-Table analysis; pp. 19–25.
    1. van Dongen J A, Voogd A C, Fentiman I S, Legrand C, Sylvester R J, Tong D, van der Schueren E, Helle P A, van Zijl K, Bartelink H. Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. JNCI Journal of the National Cancer Institute. 2000;92:1143–1150. doi: 10.1093/jnci/92.14.1143.
    1. Straus K, Lichter A, Lippman M, Danforth D, Swain S, Cowan K, deMoss E, MacDonald H, Steinberg S, d'Angelo T. Results of the National Cancer Institute early breast cancer trial. J Natl Cancer Inst Monogr. 1992;11:27–32.
    1. Fentiman IS. Long-term follow-up of the first breast conservation trial: Guy' wide excision study. Breast. 2000;5:8–9.
    1. Fortin A, Larochelle M, Laverdiere J, Lavertu S, Tremblay D. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999;17:101–109.
    1. Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med. 1995;333:1444–55. doi: 10.1056/NEJM199511303332202.
    1. EBCTCG. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and on 15-year survival: an overview of the randomised trials. The Lancet. 2005;366:2087–2106.
    1. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–55. doi: 10.1056/NEJM199710023371401.
    1. Petit JY, Veronesi U, Luini A, Orecchia R, Rey PC, Martella S, Didier F, De Lorenzi F, Rietjens M, Garusi C, Sonzogni A, Galimberti V, Leida E, Lazzari R, Giraldo A. When mastectomy becomes inevitable: the nipple-sparing approach. Breast. 2005;14:527–31. doi: 10.1016/j.breast.2005.08.028.
    1. Chagpar AB. Skin-sparing and nipple-sparing mastectomy: preoperative, intraoperative, and postoperative considerations. Am Surg. 2004;70:425–32.
    1. Toth BA, Lappert P. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plastic and Reconstructive Surgery. 1991;87:1048–53. doi: 10.1097/00006534-199106000-00006.
    1. Ho CM, Mak CK, Lau Y, Cheung WY, Chan MC, Hung WK. Skin involvement in invasive breast carcinoma: safety of skin-sparing mastectomy. Ann Surg Oncol. 2003;10:102–7. doi: 10.1245/ASO.2003.05.001.
    1. Torresan RZ, dos Santos CC, Okamura H, Alvarenga M. Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol. 2005;12:1037–44. doi: 10.1245/ASO.2005.11.027.
    1. Slavin SA, Schnitt SJ, Duda RB, Houlihan MJ, Koufman CN, Morris DJ, Troyan SL, Goldwyn RM. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer. Plast Reconstr Surg. 1998;102:49–62. doi: 10.1097/00006534-199807000-00008.
    1. Newman LA, Kuerer HM, Hunt KK, Kroll SS, Ames FC, Ross MI, Feig BW, Singletary SE. Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol. 1998;5:620–6. doi: 10.1007/BF02303832.
    1. Simmons RM, Fish SK, Gayle L, La Trenta GS, Swistel A, Christos P, Osborne MP. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol. 1999;6:676–81. doi: 10.1007/s10434-999-0676-1.
    1. Kroll SS, Khoo A, Singletary SE, Ames FC, Wang BG, Reece GP, Miller MJ, Evans GR, Robb GL. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up Plast Reconstr Surg. 1999. pp. 421–5.
    1. Rivadeneira DE, Simmons RM, Fish SK, Gayle L, La Trenta GS, Swistel A, Osborne MP. Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence. Cancer J. 2000;5:331–5.
    1. Medina-Franco H, Vasconez LO, Fix RJ, Heslin MJ, Beenken SW, Bland KI, Urist MM. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg. 2002;235:814–9. doi: 10.1097/00000658-200206000-00008.
    1. Foster RD, Esserman LJ, Anthony JP, Hwang ES, Do H. Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol. 2002;9:462–6. doi: 10.1007/BF02557269.
    1. Carlson GW, Styblo TM, Lyles RH, Bostwick J, Murray DR, Staley CA, Wood WC. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol. 2003;10:108–12. doi: 10.1245/ASO.2003.03.053.
    1. Greenway RM, Schlossberg L, Dooley WC. Fifteen-year series of skin-sparing mastectomy for stage 0 to 2 breast cancer. Am J Surg. 2005;190:918–22. doi: 10.1016/j.amjsurg.2005.08.035.
    1. Margulies AG, Hochberg J, Kepple J, Henry-Tillman RS, Westbrook K, Klimberg VS. Total skin-sparing mastectomy without preservation of the nipple-areola complex. Am J Surg. 2005;190:907–12. doi: 10.1016/j.amjsurg.2005.08.019.
    1. Yano K, Hosokawa K, Masuoka T, Matsuda K, Takada A, Taguchi T, Tamaki Y, Noguchi S. Options for immediate breast reconstruction following skin-sparing mastectomy. Breast Cancer. 2007;14:406–13. doi: 10.2325/jbcs.14.406.
    1. Patani N, Devalia H, Anderson A, Mokbel K. Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction. Surg Oncol. 2008;17:97–105. doi: 10.1016/j.suronc.2007.11.004.
    1. Scholz T, Kretsis V, Kobayashi MR, Evans GR. Long-term outcomes after primary breast reconstruction using a vertical skin pattern for skin-sparing mastectomy. Plast Reconstr Surg. 2008;122:1603–11. doi: 10.1097/PRS.0b013e31818a9a0a.
    1. Ueda S, Tamaki Y, Yano K, Okishiro N, Yanagisawa T, Imasato M, Shimazu K, Kim SJ, Miyoshi Y, Tanji Y, Taguchi T, Noguchi S. Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast. Surgery. 2008;143:414–25. doi: 10.1016/j.surg.2007.10.006.
    1. Garwood ER, Moore D, Ewing C, Hwang ES, Alvarado M, Foster RD, Esserman LJ. Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg. 2009;249:26–32. doi: 10.1097/SLA.0b013e31818e41a7.
    1. Gerber B, Krause A, Dieterich M, Kundt G, Reimer T. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg. 2009;249:461–8. doi: 10.1097/SLA.0b013e31819a044f.
    1. Bailey MH, Smith JW, Casas L, Johnson P, Serra E, de la Fuente R, Sullivan M, Scanlon EF. Immediate breast reconstruction: reducing the risks. Plast Reconstr Surg. 1989;83:845–51. doi: 10.1097/00006534-198905000-00011.
    1. Noone RB, Murphy JB, Spear SL, Little JW. A 6-year experience with immediate reconstruction after mastectomy for cancer. Plast Reconstr Surg. 1985;76:258–69. doi: 10.1097/00006534-198508000-00012.
    1. Woerdeman LA, Hage JJ, van Turnhout AA. Extended deepithelialization to secure double-breasted closure of the skin. Ann Plast Surg. 2005. pp. 338–40.
    1. Corral CJ, Mustoe TA. Controversy in breast reconstruction. Surg Clin North Am. 1996;76:309–26. doi: 10.1016/S0039-6109(05)70441-2.
    1. Krueger EA, Wilkins EG, Strawderman M, Cederna P, Goldfarb S, Vicini FA, Pierce LJ. Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys. 2001;49:713–21.
    1. Taylor CW, Horgan K, Dodwell D. Oncological aspects of breast reconstruction. The Breast. 2005;14:118–130. doi: 10.1016/j.breast.2004.08.006.
    1. Persichetti P, Cagli B, Simone P, Cogliandro A, Fortunato L, Altomare V, Trodella L. Implant breast reconstruction after salvage mastectomy in previously irradiated patients. Ann Plast Surg. 2009;62:350–4. doi: 10.1097/SAP.0b013e318184aac8.
    1. Ascherman JA, Hanasono MM, Newman MI, Hughes DB. Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg. 2006;117:359–65. doi: 10.1097/01.prs.0000201478.64877.87.
    1. Cordeiro PG, Pusic AL, Disa JJ, McCormick B, VanZee K. Irradiation after Immediate Tissue Expander/Implant Breast Reconstruction: Outcomes, Complications, Aesthetic Results, and Satisfaction among 156 Patients. Plast Reconstr Surg. 2004;113:877–81. doi: 10.1097/01.PRS.0000105689.84930.E5.
    1. Paulhe P, Aubert JP, Magalon G. Forum on tissue expansion. Are tissue expansion and radiotherapy compatible? Apropos of a series of 50 consecutive breast reconstructions. Ann Chir Plast Esthet. 1993;38:54–61.
    1. Santini D, Taffurelli M, Gelli MC, Grassigli A, Giosa F, Marrano D, Martinelli G. Neoplastic involvement of nipple-areolar complex in invasive breast cancer. Am J Surg. 1989;158:399–403. doi: 10.1016/0002-9610(89)90272-9.
    1. Laronga C, Kemp B, Johnston D, Robb GL, Singletary SE. The incidence of occult nippleeareola complex involvement in breast cancer patients receiving skin-sparing mastectomy. Annals of Surgical Oncology. 1999;6:609–13. doi: 10.1007/s10434-999-0609-z.
    1. Sikand K, Lee AH, Pinder SE, Elston CW, Ellis IO. Sections of the nipple and quadrants in mastectomy specimens for carcinoma are of limited value. Journal of Clinical Pathology. 2005;58:543–5. doi: 10.1136/jcp.2004.022665.
    1. Vlajcic Z, Zic R, Stanec S, Lambasa S, Petrovecki M, Stanec Z. Nipple-areola complex preservation: predictive factors of neoplastic nipple-areola complex invasion. Ann Plast Surg. 2005;55:240–4. doi: 10.1097/01.sap.0000171680.49971.85.
    1. Petit JY, Veronesi U, Orecchia R, Luini A, Rey P, Intra M, Didier F, Martella S, Rietjens M, Garusi C, DeLorenzi F, Gatti G, Leon ME, Casadio C. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. Breast Cancer Res Treat. 2006;96:47–51. doi: 10.1007/s10549-005-9033-7.
    1. Gulben K, Yildirim E, Berberoglu U. Prediction of occult nipple-areola complex involvement in breast cancer patients. Neoplasma. 2009;56:72–5. doi: 10.4149/neo_2009_01_72.
    1. Sookhan N, Boughey JC, Walsh MF, Degnim AC. Nipple-sparing mastectomy--initial experience at a tertiary center. Am J Surg. 2008;196:575–7. doi: 10.1016/j.amjsurg.2008.06.022.
    1. Brachtel E, Rusby J, Michaelson J, Chen L, Muzikansky A, Smith B, Koerner F. Occult Nipple Involvement in Breast Cancer: Clinicopathologic Findings in 316 Consecutive Mastectomy Specimens. JCO. 2009;27(30):4948–54. doi: 10.1200/JCO.2008.20.8785.
    1. Crowe JP Jr, Kim JA, Yetman R, Banbury J, Patrick RJ, Baynes D. Nipple-sparing mastectomy: technique and results of 54 procedures. Arch Surg. 2004;139:148–50. doi: 10.1001/archsurg.139.2.148.
    1. Caruso F, Ferrara M, Castiglione G, Trombetta G, De Meo L, Catanuto G, Carillio G. Nipple sparing subcutaneous mastectomy: sixty-six months follow-up. Eur J Surg Oncol. 2006;32:937–40. doi: 10.1016/j.ejso.2006.05.013.
    1. Sacchini V, Pinotti JA, Barros AC, Luini A, Pluchinotta A, Pinotti M, Boratto MG, Ricci MD, Ruiz CA, Nisida AC, Veronesi P, Petit J, Arnone P, Bassi F, Disa JJ, Garcia-Etienne CA, Borgen PI. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14. doi: 10.1016/j.jamcollsurg.2006.07.015.
    1. Komorowski AL, Zanini V, Regolo L, Carolei A, Wysocki WM, Costa A. Necrotic complications after nipple- and areola-sparing mastectomy. World J Surg. 2006;30:1410–3. doi: 10.1007/s00268-005-0650-4.
    1. Stolier AJ, Sullivan SK, Dellacroce FJ. Technical considerations in nipple-sparing mastectomy: 82 consecutive cases without necrosis. Ann Surg Oncol. 2008;15:1341–7. doi: 10.1245/s10434-007-9753-5.
    1. Voltura AM, Tsangaris TN, Rosson GD, Jacobs LK, Flores JI, Singh NK, Argani P, Balch CM. Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteria. Ann Surg Oncol. 2008;15:3396–401. doi: 10.1245/s10434-008-0102-0.
    1. Simmons RM, Hollenbeck ST, Latrenta GS. Two-year follow-up of areola-sparing mastectomy with immediate reconstruction. Am J Surg. 2004;188:403–6. doi: 10.1016/j.amjsurg.2004.07.001.
    1. Denewer A, Farouk O. Can Nipple-sparing Mastectomy and Immediate Breast Reconstruction with Modified Extended Latissimus Dorsi Muscular Flap Improve the Cosmetic and Functional Outcome among Patients with Breast Carcinoma? World J Surg. 2007;31:1171–1179. doi: 10.1007/s00268-007-9046-y.
    1. Crowe JP, Patrick RJ, Yetman RJ, Djohan R. Nipple-sparing mastectomy update: one hundred forty-nine procedures and clinical outcomes. Arch Surg. 2008;143:1106–10. doi: 10.1001/archsurg.143.11.1106.
    1. Gerber B, Krause A, Dieterich M, Kundt G, Reimer T. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg. 2009;249:461–8. doi: 10.1097/SLA.0b013e31819a044f.
    1. Petit JY, Veronesi U, Orecchia R, Rey P, Martella S, Didier F, Viale G, Luini A, Galimberti V, Bedolis R, Rietjens M, Garusi C, De Lorenzi F, Bosco R, Banconi A, Ivaldi GB, Youssef O. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European Institute on oncology in Milan (IEO) Breast Cancer Res Treat. 2009;117:333–8. doi: 10.1007/s10549-008-0304-y.
    1. Benediktsson KP, Perbeck L. Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients. Eur J Surg Oncol. 2008;249:143–8.
    1. Rainsbury RM, Paramanathan N. UK survey of partial mastectomy and reconstruction. Breast. 2007;16:637–45. doi: 10.1016/j.breast.2007.05.009.
    1. Kaur N, Petit JY, Rietjens M, Maffini F, Luini A, Gatti G, Rey PC, Urban C, De Lorenzi F. Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol. 2005;12:539–45. doi: 10.1245/ASO.2005.12.046.
    1. Fitzal F, Mittlboeck M, Trischler H, Krois W, Nehrer G, Deutinger M, Jakesz R, Gnant M. Breast-conserving therapy for centrally located breast cancer. Ann Surg. 2008;247:470–6. doi: 10.1097/SLA.0b013e31815b6991.
    1. Giacalone PL, Roger P, Dubon O, El Gareh N, Rihaoui S, Taourel P, Daurés JP. Comparative study of the accuracy of breast resection in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol. 2007;14:605–14. doi: 10.1245/s10434-006-9098-5.
    1. Fisher ER, Gregorio RM, Fisher B. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol n. 04) Cancer. 1975;36:1–85. doi: 10.1002/1097-0142(197507)36:1<1::AID-CNCR2820360102>;2-4.
    1. Lagios MD, Gates EA, Westdahl PR, Richards V, Alpert BS. A guide to the frequency of nipple involvement in breast cancer: A study of 149 consecutive mastectomies using a serial subgross and correlated radiographic technique. Am J Surg. 1979;138:135–42. doi: 10.1016/0002-9610(79)90253-8.
    1. Rosen PP, Fracchia AA, Urban JA, Schottenfield D, Robbins G. Residual mammary carcinoma simulated partial mastectomy. Cancer. 1975. pp. 739–47.
    1. Nogushi M, Earashi M, Kinoshita K, Taniya T, Miyazaki II. A case with breast cancer under the nipple who underwent breast conserving treatment. Breast Cancer. 1994;30:157–60. doi: 10.1007/BF02967047.
    1. Galimberti V, Zurrida S, Zanini V, Callegari M, Veronesi P, Catania S, Luini A, Greco M, Grisotti A. Central small size breast cancer: How to overcome the problem of nipple and areola involvement. Eur J Cancer. 1993;29:1093–6. doi: 10.1016/S0959-8049(05)80294-1.
    1. Haffty BG, Wilson LD, Smith R, Fischer D, Beinfield M, Ward B, McKhann C. Subareolar breast cancer: long-term results with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:53–7.
    1. Simmons RM, Brennan MB, Christos P, Sckolnick M, Osborne M. Recurrence rates in patients with central or retroareolar breast cancers treated with mastectomy or lumpectomy. Am J Surg. 2001;182:325–9. doi: 10.1016/S0002-9610(01)00721-8.
    1. Pezzi CM, Kukora JS, Audet IM, Herbert SH, Horvick D, Richter MP. Breast conservation surgery using nipple-areolar resection for central breast cancers. Arch Surg. 2004;139:32–7. doi: 10.1001/archsurg.139.1.32.
    1. Tausch C, Hintringer T, Kugler F, Schmidhammer C, Bauer M, Aufschnaiter M. Breast-conserving surgery with resection of the nipple-areola complex for subareolar breast carcinoma. Br J Surg. 2005;92:1368–1371. doi: 10.1002/bjs.5083.
    1. Naguib SF. Oncoplastic resection of retroareolar breast cancer: central quadrantectomy and reconstruction by local skin-glandular flap. J Egypt Natl Canc Inst. 2006;139:334–47.
    1. Huemer GM, Schrenk P, Moser F, Wagner E, Wayand W. Oncoplastic techniques allow breast-conserving treatment in centrally located breast cancers. Plast Reconstr Surg. 2007;139:390–8. doi: 10.1097/01.prs.0000267328.09246.02.
    1. Wagner E, Schrenk P, Huemer GM, Sir A, Schreiner M, Wayand W. Central quadrantectomy with resection of the nipple-areola complex compared with mastectomy in patients with retroareolar breast cancer. Breast J. 2007;13:557–63. doi: 10.1111/j.1524-4741.2007.00492.x.
    1. Gajdos C, Tartter PI, Bleiweiss IJ. Subareolar breast cancers. Am J Surg. 2000;180:167–170. doi: 10.1016/S0002-9610(00)00477-3.
    1. Dale PS, Giuliano AE. Nipple-areolar preservation during breastconserving therapy for subareolar breast carcinomas. Arch Surg. 1996;131:430–3.
    1. Fowble B, Solin LJ, Schultz DJ, Weiss MC. Breast recurrence and survival related to primary tumor location in patients undergoing conservative surgery and radiation for early stage breast cancer. Int JRadiat Oncol Biol Physic. 1992;23:933–9.
    1. Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer. N Engl J Med. 1992;327:473–80.
    1. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, Herndon JE, Giuliano AE. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491–500. doi: 10.1245/ASO.2006.05.013.
    1. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer. 2006;106:4–16. doi: 10.1002/cncr.21568.
    1. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S. et al.Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnairebased survey by the European Working Group for Breast Screening Pathology. J Clin Pathol. 2005;57:695–701. doi: 10.1136/jcp.2003.013599.
    1. Fortunato L, Amini M, Costarelli L, Piro FR, Farina M, Vitelli CE. A standardized sentinel lymph node enhanced pathology protocol (SEPP) in patients with breast cancer. J Surg Oncol. 2007;1(470):3–96.
    1. Cronin-Fenton DP, Ries LA, Clegg LX, Edwards BK. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement. J Natl Cancer Inst. 2007;99:1044–9. doi: 10.1093/jnci/djm026.
    1. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565–8.
    1. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997;80:1188–97. doi: 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>;2-H.
    1. Tan LK, Giri D, Panageas K. Occult micrometastases in axillary lymph nodes of breast cancer patients are significant: a retrospective study with long-term follow-up (abstract) Proc Am Soc Clin Oncol. 2002;21:37.
    1. Colleoni M, Rotmensz N, Peruzzotti G. et al.Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005;23:1379–89. doi: 10.1200/JCO.2005.07.094.
    1. de Boer M, van Deurzen C, van Dijck J, Borm G, van Diest P, Adang E, Nortier J, Rutgers E, Seynaeve C, Menke-Pluymers M, Bult P, Tjan-Heijnen V. Micrometastases or isolated tumor cells and the outcome of breast cancer. NEJM. 2009;361:653–663. doi: 10.1056/NEJMoa0904832.
    1. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol. 1999;17:1720–6.
    1. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, Giuliano AE. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer. 2000;1(89):574–81. doi: 10.1002/1097-0142(20000801)89:3<574::AID-CNCR12>;2-Y.
    1. Nos C, Harding-MacKean C, Fréneaux P, Trie A, Falcou MC, Sastre-Gara X, Clough KB. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg. 2003;17:1354–60. doi: 10.1002/bjs.4325.
    1. Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10:248–54. doi: 10.1245/ASO.2003.05.020.
    1. Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol. 2005;12:705–11. doi: 10.1245/ASO.2005.08.020.
    1. Rutledge H, Davis J, Chiu R, Cibull M, Brill Y, McGrath P, Samayoa L. Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol. 2005;18:762–8. doi: 10.1038/modpathol.3800394.
    1. Schrenk P, Konstantiniuk P, Wölfl S, Bogner S, Haid A, Nemes C, Jagoutz-Herzlinger M, Redtenbacher S. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg. 2005;92:707–13. doi: 10.1002/bjs.4937.
    1. van Rijk MC, Peterse JL, Nieweg OE, Oldenburg HS, Rutgers EJ, Kroon BB. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer. 2006;1(107):467–71. doi: 10.1002/cncr.22069.
    1. White RL Jr, Wilke LG. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg. 2004;70:420–4.
    1. Krag DN, Julian TB, Harlow SP, Weaver DL, Ashikaga T, Bryant J, Single RM, Wolmark N. NSABP-32: phase III randomized trial comparing axillary resection with sentinel lymph node dissection. A description of the trial. Ann Surg Oncol. 2004;11(Suppl 3):208S–10S.
    1. National Cancer Institute, US National Institute of Health clinical trials; International Breast Cancer Study Group (IBCSG) Galimberti V Trial 23-01. Phase III randomized study of surgical resection with or without axillary lymph node dissection in women with a clinically node-negative breast cancer with a sentinel micrometastasis.
    1. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM. Detection of ductal carcinoma in situ in women undergoing screening mammography. Natl Cancer Inst. 2002;16(94):1546–54.
    1. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96:906–20.
    1. Zavagno G, Carcoforo P, Marconato R, Franchini Z, Scalco G, Burelli P, Pietrarota P, Lise M, Mencarelli R, Capitanio G, Ballarin A, Pierobon ME, Marconato G, Nitti D. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer. 2005;5:28. doi: 10.1186/1471-2407-5-28.
    1. Veronesi P, Intra M, Vento AR. Sentinel lymph node biopsy for localized ductal carcinoma in situ? Breast. 2005;14:520–2. doi: 10.1016/j.breast.2005.08.007.
    1. Ansari B, Ogston SA, Purdie CA, Adamson DJ, Brown DC, Thompson A. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg. 2008;95:547–554. doi: 10.1002/bjs.6162.
    1. Zavotsky J, Hansen N, Brennan MB, Turner RR, Giuliano AE. Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer. 1999;85:2439–43. doi: 10.1002/(SICI)1097-0142(19990601)85:11<2439::AID-CNCR19>;2-J.
    1. Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, Heerdt A, Montgomery L, Paglia M, Petrek JA, Cody HS, Van Zee KJ. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol. 2000;7:636–42. doi: 10.1007/s10434-000-0636-2.
    1. Wasserberg N, Morgenstern S, Schachter J, Fenig E, Lelcuk S, Gutman H. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component. Arch Surg. 2002;137:1249–52. doi: 10.1001/archsurg.137.11.1249.
    1. Intra M, Zurrida S, Maffini F, Sonzogni A, Trifirò G, Gennari R, Arnone P, Bassani G, Opazo A, Paganelli G, Viale G, Veronesi U. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol. 2003;10:1160–5. doi: 10.1245/ASO.2003.04.009.
    1. Le Bouëdec G, Gimbergues P, Feillel V, Penault-Llorca F, Dauplat. In situ mammary duct carcinoma with microinvasion. Which axillary lymph node exploration? Presse Med. 2005;12(34):208–12. doi: 10.1016/S0755-4982(05)88249-1.
    1. Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S. Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol. 2006;1(94):426–30. doi: 10.1002/jso.20578.
    1. Zavagno G, Belardinelli V, Marconato R, Carcoforo P, Franchini Z, Scalco G, Burelli P, Pietrarota P, Mencarelli R, Marconato G, Nitti D. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast. 2007;16:146–51. doi: 10.1016/j.breast.2006.08.002.
    1. Fortunato L, Santoni M, Drago S, Gucciardo G, Farina M, Cesarini C, Cabassi A, Tirelli C, Terribile D, Grassi GB, De Fazio S, Vitelli CE; Rome Breast Cancer Study Group. Sentinel lymph node biopsy in women with pT1a or "microinvasive" breast cancer. Breast. 2008. pp. 395–400.
    1. Doyle B, Al-Mudhaffer M, Kennedy MM, O'Doherty A, Flanagan F, McDermot EW, Kerin MJ, Hill AD, Quinn CM. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of DCIS - is it justified? J Clin Pathol. 2009;62:534–538. doi: 10.1136/jcp.2008.061457.
    1. Rubio IT, Roca I, Sabadell D, Xercavins J. Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ Cir Esp. 2009. pp. 92–5.
    1. Polom K, Murawa D, Wasiewicz J, Nowakowski W, Murawa P. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Eur J Surg Oncol. 2009;35:43–7.
    1. van Deurzen CH, Hobbelink MG, van Hillegersberg R, van Diest PJ. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. Eur J Cancer. 2007;43:993–1001. doi: 10.1016/j.ejca.2007.01.010.
    1. Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F, Salvatori B. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;4(87):19–27. doi: 10.1093/jnci/87.1.19.
    1. Sood A, Youssef IM, Heiba SI, El-Zeftawy H, Axelrod D, Seigel B, Mills C, Abdel-Dayem HM. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med. 2004;29:698–702. doi: 10.1097/00003072-200411000-00005.
    1. Agarwal A, Heron DE, Sumkin J, Falk J. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer. J Surg Oncol. 2005;92:4–8. doi: 10.1002/jso.20282.
    1. Roumen RMH, Kuijy GP, Liem LH. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol. 2006;32:1076–81. doi: 10.1016/j.ejso.2006.08.007.
    1. Newman EA, Cimmino VM, Sabel MS, Diehl KM, Frey KA, Chang AE, Newman LA. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol. 2006;13:52–7. doi: 10.1245/ASO.2006.12.002.
    1. Taback B, Nguyen P, Hansen N, Edwards GK, Conway K, Giuliano AE. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol. 2006;13:1099–104. doi: 10.1245/ASO.2006.08.026.
    1. Intra M, Trifiro G, Galimberti V, Gentilini O, Rotmensz N, Veronesi P. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg. 2007;94:1216–9. doi: 10.1002/bjs.5813.
    1. Port ER, Garcia-Etienne CA, Park J, Fey J, Borgen PI, Cody HS. Reoperative sentinel lymph node biopsy: a newfrontier in th emanagement of ipsilateral breast tumor recurrence. Ann SurgOncol. 2007;14:2209–14.
    1. Barone JL, Feldman SM, Estabrook A, Tartter PI, Rosenbaum Smith SM, Boolbol SK. Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer. Am J Surg. 2007;194:491–3. doi: 10.1016/j.amjsurg.2007.07.011.
    1. Axelsson CK, Jønsson PE. Sentinel lymph node biopsy in operations for recurrent breast cancer. Eur J Surg Oncol. 2008;34:626–30.
    1. Koizumi M, Koyama M, Tada K, Nishimura S, Miyagi Y, Makita M, Yoshimoto M, Iwase T, Horii R, Akiyama F, Saga T. The feasibility of sentinel node biopsy in the previously treated breast. Eur J Surg Oncol. 2008;34:365–8.
    1. Breslin TM, Cohen LF, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000;18:3480–4.
    1. Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg. 2001;182:312–5. doi: 10.1016/S0002-9610(01)00718-8.
    1. Fernandez A, Cortes M, Benito E, Azpeitia D, Prieto L, Moreno A, Ricart Y, Mora J, Escobedo A, Martín Comín J. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun. 2001;22:361–6. doi: 10.1097/00006231-200104000-00003.
    1. Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2002;184:315–7. doi: 10.1016/S0002-9610(02)00955-8.
    1. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol. 2002;9:235–42. doi: 10.1007/BF02573060.
    1. Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J. 2002;8:97–100. doi: 10.1046/j.1524-4741.2002.08205.x.
    1. Schwartz GF, Meltzer AJ. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J. 2003;9:374–9. doi: 10.1046/j.1524-4741.2003.09502.x.
    1. Piato JR, Barros AC, Pincerato KM, Sampaio AP, Pinotti JA. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol. 2003;29:118–20. doi: 10.1053/ejso.2002.1349.
    1. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol. 2003;84:63–7. doi: 10.1002/jso.10294.
    1. Kang SH, Kim SK, Kwon Y, Kang HS, Kang JH, Ro J, Lee ES. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg. 2004;28:1019–24. doi: 10.1007/s00268-004-7367-7.
    1. Lang JE, Esserman LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, Hwang ES. Accuracy of sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg. 2004;199:856–62. doi: 10.1016/j.jamcollsurg.2004.08.023.
    1. Shimazu K, Tamaki Y, Taguchi T, Akazawa K, Inoue T, Noguchi S. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer. 2004;100:2555–61. doi: 10.1002/cncr.20242.
    1. Balch GC, Mithani SK, Richards KR, Beauchamp RD, Kelley MC. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol. 2003;10:616–21. doi: 10.1245/ASO.2003.05.012.
    1. Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, Bear HD, Caldwell CB, Walker AP, Mikkelson WM, Stauffer JS, Robidoux A, Theoret H, Soran A, Fisher B, Wickerham DL, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2005;23:2694–702. doi: 10.1200/JCO.2005.05.188.
    1. Tausch C, Konstantiniuk P, Kugler F, Reitsamer R, Roka S, Pöstlberger S, HaidA.Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol. 2006. in press .
    1. Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol. 2007;14:2946–52. doi: 10.1245/s10434-007-9374-z.
    1. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer. 2007;109:1255–63. doi: 10.1002/cncr.22540.
    1. Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer. 2007;14:10–5. doi: 10.2325/jbcs.14.10.
    1. Hino M, Sano M, Sato N, Homma K. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surg Today. 2008. pp. 585–91.
    1. Classe JM, Bordes V, Campion L, Mignotte H, Dravet F, Leveque J, Sagan C, Dupre PF, Body G, Giard S. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol. 2009;27:726–32. doi: 10.1200/JCO.2008.18.3228.
    1. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymph node staging for patients with multicentric breast cancer. Lancet. 2001. pp. 357–122.
    1. Fernandez K, Swanson M, Verbanac K. Is sentinel lymphadenectomy accurate in multifocal and multicentric breast cancer? [abstract 29] Proceedings of the 55th Annual Cancer Symposium of the Society of Surgical Oncology. 2002. pp. S9–16.
    1. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, Bernik S, Mills C, Wallack M, Abdel-Dayem HM. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable or non palpable breast cancer. J Nucl Med. 2003;44:7–10.
    1. Tousimis E, Van Zee KJ, Fey JV, Hoque LW, Tan LK, Cody HS, Borgen PI, Montgomery LL. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg. 2003;197:529–35. doi: 10.1016/S1072-7515(03)00677-X.
    1. Goyal A, Newcombe RG, Mansel RE. Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol. 2004;30:475–9. doi: 10.1016/j.ejso.2004.02.009.
    1. Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Pöstlberger S, Reitsamer R, Schrenk P. Multicentric breast cancer: a new indication for sentinel node biopsyda multi-institutional validation study. J Clin Oncol. 2006;24:3374–80. doi: 10.1200/JCO.2006.05.7372.
    1. Ferrari A, Dionigi P, Rovera F, Boni L, Limonta G, Garancini S, De Palma D, Dionigi G, Vanoli C, Diurni M, Carcano G, Dionigi R. Multifocality and multicentricity are not contraindications for sentinel lymph node biopsy in breast cancer surgery. World J Surg Oncol. 2006;4:79–8. doi: 10.1186/1477-7819-4-79.
    1. Gentilini O, Trifiro' G, Soteldo J, Luini A, Intra M, Galimberti V, Veronesi P, Silva L, Gandini S, Paganelli G, Veronesi U. Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. Ann Surg Oncol. 2006;32:507–10.
    1. D'Eredita G, Giardina C, Ingravallo G, Rubini G, Lattanzio V, Berardi T. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer. Breast. 2007;16:316–22. doi: 10.1016/j.breast.2006.12.012.
    1. Cipolla C, Vieni S, Fricano S, Cabibi D, Graceffa G, Costa R, Latteri S, Latteri MA. The accuracy of sentinel lymph node biopsy in the treatment of multicentric invasive breast cancer using a subareolar injection of tracer. World J Surg. 2008;32:2483–7. doi: 10.1007/s00268-008-9719-1.
    1. Lo YF, Cheung YC, Hsueh S, Ho KC. Feasibility of sentinel lymph node biopsy in multifocal/multicentric breast cancer. Chang Gung Med J. 2009;32:51–8.
    1. Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial. Eur J Cancer. 1999;35:1320–1325. doi: 10.1016/S0959-8049(99)00133-1.
    1. Estourgie SH, Nieweg OE, Valdes Olmos RA, Rutgers EJ, Kroon BB. Lymphatic drainage pattterns from the breast. Ann Surg. 2004;239:232–237. doi: 10.1097/01.sla.0000109156.26378.90.
    1. Turner-Warwick RT. The lymphatics of the breast. Br J Surg. 1959;46:574–82. doi: 10.1002/bjs.18004620004.
    1. Park C, Sied P, Morita E, Iwanaga K, Weinberg V, Quivey J, Hwang ES, Esserman LJ, Leong SP. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J. 2005;11:29–33. doi: 10.1111/j.1075-122X.2005.21527.x.
    1. Paganelli G, Galimberti V, Trifirò G, Travaini L, De Cicco C, Mazzarol G, Intra M, Rocca P, Prisco G, Veronesi U. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med. 2002;46:138–44.
    1. Galimberti V, Veronesi P, Arnone P, De Cicco C, Renne G, Intra M, Zurrida S, Sacchini V, Gennari R, Vento A, Luini A, Veronesi U. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol. 2002;9:924–8. doi: 10.1007/BF02557532.
    1. Farrus B, Vidal-Sicart S, Velasco M, Zanón G, Fernández PL, Muñoz M, Santamaría G, Albanell J, Biete A. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys. 2004;60:715–21.
    1. Carcoforo P, Sortini D, Feggi L, Feo CV, Soliani G, Panareo S, Corcione S, Querzoli P, Maravegias K, Lanzara S, Liboni A. Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. Ann Surg Oncol. 2006;13:1338–43. doi: 10.1245/s10434-006-9062-4.
    1. Spillane AJ, Noushi F, Cooper RA, Gebski V, Uren RF. High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer. Annali of Oncolology. 2009;20:977–984. doi: 10.1093/annonc/mdn725.
    1. Heuts EM, Ent FWC van der, von Meyenfeldt MF, Voogd AC. Internal mammari lymph node drainage and sentinel node biopsyin breast cancer- A study on 1008 patients. EJSO. 2009;35:252–257.
    1. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747–1751. doi: 10.1001/jama.280.20.1747.
    1. Hannan EL, O'Donnell JF, Kilburn H Jr, Bernard HR, Yazici A. Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals. JAMA. 1989;262:503–510. doi: 10.1001/jama.262.4.503.
    1. Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg. 1995;221:43–9. doi: 10.1097/00000658-199501000-00005.
    1. Simunovic M, To T, Langer B. Influence of hospital volume on mortality following major cancer surgery. JAMA. 1999;281:1374–5. doi: 10.1001/jama.281.15.1374.
    1. Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg. 1999;134:30–5. doi: 10.1001/archsurg.134.1.30.
    1. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med. 1979;301:1364–9.
    1. Farber BF, Kaiser DL, Wenzel RP. Relation between surgical volume and incidence of postoperative wound infection. N Engl J Med. 1981;305:200–4.
    1. Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005;242:540–4.
    1. Guller U, Safford S, Pietrobon R, Heberer M, Oertli D, Jain NB. High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients. World J Surg. 2005;29:994–9. doi: 10.1007/s00268-005-7831-z.
    1. Gutierrez JC, Hurley JD, Housri N, Perez EA, Byrne MM, Koniaris LG. Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients. Ann Surg. 2008;248:154–62. doi: 10.1097/SLA.0b013e31816c4030.
    1. Skinner KA, Helsper JT, Deapen D, Ye W, Sposto R. Breast cancer: do specialists make a difference? Ann Surg Oncol. 2003;10(6):606–15. doi: 10.1245/ASO.2003.06.017.
    1. Copeland EM III. Surgical oncology: a specialty in evolution. Ann Surg Oncol. 1999;6:424–32.
    1. Cataliotti L, Costa A, Daly PA, Fallowfield L, Freilich G, Holmberg L, Piccart M, Velde CJ van de, Veronesi U. Florence Statement on Breast Cancer, 1998 Forging the Way Ahead for More Research on and Better Care in Breast Cancer. European Journal of Cancer. 1999;35:14–5. doi: 10.1016/S0959-8049(98)00384-0.
    1. The Hamburg Statement. The partnership driving the European agenda on breast cancer. European Journal of Cancer. 2004;40:1810–11. doi: 10.1016/j.ejca.2004.04.020.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe